Medullary thyroid carcinoma without marked elevation of calcitonin: A diagnostic and surveillance dilemma

Thyroid

Volumn 18, Issue 8, 2008, Pages 889-894

  Wang, Tracy S ^a   Ocal, Idris Tolgay ^b,c   Sosa, Julie Ann ^c   Cox, Heather ^d   Roman, Sanziana ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MAYO CLINIC   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER SURVIVAL; CASE REPORT; DIAGNOSTIC VALUE; DISEASE FREE INTERVAL; HUMAN; INTERNAL JUGULAR VEIN; LYMPH NODE DISSECTION; MALE; NECK METASTASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL TIME; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; VEIN SURGERY;

EID: 50649083690     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0413     Document Type: Article

References (25)

1. Roman S, Lin R, Sosa JA 2006 Prognosis of medullary thyroid cancer. Cancer 107:2134-2142.
2. Carling T, Udelsman R 2005 Cancer of the endocrine system: thyroid tumors. In: Devita VT, Hellman S, Rosenberg SA (eds) Cancer: Principle & Practice of Oncology, seventh edition. Lippincott Williams and Wilkins, Philadelphia, p 1502.
3. Wells SA Franz C 2000 Medullary carcinoma of the thyroid gland. World J Surg 24:952-956.
4. Kebebew E, Ituarte PHG, Siperstein AE, Duh QY, Clark OH 2000 Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139-1148.
5. Redding AH, Levine SN, Fowler MR 2000 Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 10:919-922.
6. Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE 2004 Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid 14:468-470.
7. Diez JJ, Iglesias P 2004 Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid 14:984-985.
8. Sand M, Gelos M, Sand D, Bechara GFG, Bonhag G, Welsing E, Mann B 2006 Serum calcitonin negative medullary thyroid carcinoma. World J Surg Oncol 4:97-100.
9. Schmid KW, Ensinger C 1998 "Atypical" medullary thyroid carcinoma with little or no calcitonin expression. Virchows Arch 433:209-215.
10. LiVolsi VA 1990 Surgical Pathology Of The Thyroid (Major Problems in Pathology, Vol 22) Saunders, Philadelphia.
11. Busseniers AE, Silver SA 2007 Fine-needle aspiration cytology of the thyroid. In: Oertli D, Udelsman R (eds) Surgery of the Thyroid and Parathyroid Glands. Springer, Berlin Heidelberg New York, p 61.
12. Mihaie R, Farndon JR 2003 Medullary carcinoma of the thyroid. In: Randolph G (ed) Surgery of the Thyroid and Parathyroid Glands. Saunders, Philadelphia, p 232.
13. Constante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S 2006 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450-455.
14. Gimm O 2007 Surgery for medullary thyroid cancer. In: Oertli D, Udelsman R (eds) Surgery of the Thyroid and Parathyroid Glands. Springer, Berlin Heidelberg New York, p 147.
15. Rude RK, Signer FR 1977 Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 44:980-983.
16. Verdy M, Cholette JP, Cantin J, LaCroix A, Sturtridge WC 1978 Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma. CMA J 119:29-35.
17. Niccoli P, Brunet P, Roubicek C, Roux F, Baudin E, Lejeune PJ, Berland Y, Conte-Devolx B 1995 Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. Eur J Endocrinol 132:75-81.
18. Machens A, Haedecke J, Holzhausen JH, Thomusch O, Schneyer U, DralleH2000 Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation. Langenbecks Arch Surg 385:398-401.
19. You YN, Lakhani V, Wells SA, Moley JF 2006 Medullary thyroid cancer. Surg Oncol Clin N Am 15:639-660.
20. Clark JR, Fridman TR, Odell MJ, Brierley J, Walfish PG, Freeman JL 2005 Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope 115:1445-1450.
21. Frank-Raue K, Raue F, Buhr HJ, Baldauf G, Lorenz D, Ziegler R 1992 Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid 2:113-117.
22. 18F-flouro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 11:786-794.
23. Iagaru A, Masamed R, Singer PA, Conti PS 2007 Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose PET and PET/CT. Mol Imaging Biol 9:72-77.
24. 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 48:501-507.
25. Giraudet AL, Vanel D, Leboulleux S, Aupérin A, Dromain C, Chami L, Ny Tovo N, Lumbroso J, Lassau N, Bonniaud G, Hartl D, Travagli JP, Baudin E, Schlumberger M 2007 Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 92:4185-4190.